Icahn wins second Biogen board seat - Boston Business Journal:

plesciamipukoa1855.blogspot.com
Biogen confirmed last week the appointment of Icahn allyAlexander J. At the time, Biogen was pushing for the reelectionm of all ofthe company’s four existing directors on the ballog at its annual shareholders while Icahn was angling to seat four new Bruce R. Ross, Biogen Idec’s said, “We welcome Alexander Denner and Richarx Mulligan to the board and look forward to workinf with them to build onBiogen Idec’s strong tracik record of delivering value.” Mulligan is the Mallinckrodtr Professor of Genetics at and director of the Harvard Gene Therapt Initiative, according to ’ss Web site. Cambridge, Mass.
-based Biogen said shareholder s rejected severalof Icahn’s other proposals, including moving the company’s incorporation from Delaware to North Dakota, a move Icahn said would give more powere to shareholders. Biogen officials said it appears that stockholders also rejecte a proposal by Icahnb to limit the size of the board to 13 Biogen officials now have the power to enlarge thenow 13-membed board as they see fit. Icahn is best known for unsuccessfully pushing BiogenmIdec (Nasdaq: BIIB) to sell itself in 2008. Last shareholders elected the company’s nominees over the slatse of investors put up by Biogen Idec’s (NASDAQ: BIIB) stock was tradingh at $53.
17 in afternoon trading down from the previoues day’s close of $53.43 a share.